- Tytuł:
- Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab or Sotrovimab on Persistently High Viral Load in Patients with Mild-to-Moderate COVID-19: A Randomized, Phase 2 BLAZE-4 Trial
- Autorzy:
- Źródło:
- Infectious Diseases and Therapy. 13(2):401-411
Czasopismo naukowe